Navigation Links
McNEIL-PPC, Inc. Announces Signing of Consent Decree Covering Manufacturing Facilities in Las Piedras, PR, Fort Washington, PA, and Lancaster, PA
Date:3/10/2011

>

In April 2010, the company voluntarily closed its manufacturing facility in Fort Washington, PA and announced that it would not re-open the plant until it completed its planned remediation efforts at that facility. According to the terms of the Consent Decree, the company will not re-open the Fort Washington facility unless it first has completed remediation efforts at the facility, receives a certification of compliance from an independent expert, and then receives approval from the FDA.

McNEIL-PPC, Inc. is a subsidiary of Johnson & Johnson.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current expectations of future events.  If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from McNeil-PPC, Inc. or Johnson & Johnson's expectations and projections.  Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment.  A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 2, 2011.  Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson.  Neither McNeil-PPC, Inc. nor Johnson & Johnson undertakes to update any forward-looking statements as a result of new informati
'/>"/>

SOURCE McNEIL-PPC, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 21, 2014  CASI Pharmaceuticals, Inc. (Nasdaq: ... the treatment of cancer and other diseases, announced today ... Administration (CFDA) has approved the Company,s application to conduct ... (TNBC) patients in China for ... Ken K. Ren , Ph.D., CASI,s Chief Executive Officer, ...
(Date:7/21/2014)... , July 22, 2014 Research and ... of the "Global Coronary Stents Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 A coronary stent is a ... of stainless steel, cobalt-based alloy with mechanism of ... blockages that may occur in patients after they ...
(Date:7/18/2014)... July 18, 2014  Patient engagement is a ... marketing is one of the principal groups that ... Policy groups within the pharmaceutical industry are among ... activities and initiatives to positively impact the "patient ... firm, Best Practices, LLC, identified the key support ...
Breaking Medicine Technology:CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 2CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 3CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 4Global Coronary Stents Market 2014-2018: Key Vendors are Abbott, Boston Scientific, Medtronic and Terumo 2Global Coronary Stents Market 2014-2018: Key Vendors are Abbott, Boston Scientific, Medtronic and Terumo 3Government Affairs & Public Policy Groups Playing Critical Role in Patient Engagement, Reports Best Practices, LLC 2
... Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and ... Sachs Global Healthcare Conference on Tuesday, June 15 , at ... Los Angeles .  The presentation will be webcast on the following ... , ...
... Epocal, Inc., a leading edge provider of point ... Food and Drug Administration (FDA) clearance to market its new ... from the epoc System are used to evaluate acid-base status ... acidity of the blood).  The addition of lactate to the ...
Cached Medicine Technology:Epocal Announces FDA Clearance of Lactate Test 2
(Date:7/21/2014)... 22, 2014 Recently, Stwd.co.uk, a popular supplier ... wedding dresses. Additionally, the company’s chief executive officer has stated ... prices, up to 58% off. , “All our new and ... offer is launched to bring huge benefits to worldwide customers. ... cheap wedding outfits. By the way, we offer custom made ...
(Date:7/21/2014)... PowerObjects, a professional services firm 100% ... for Microsoft Dynamics CRM, has joined the prestigious ... of the most strategic Microsoft Dynamics partners from ... them in the highest echelon of the Microsoft ... Microsoft Dynamics Inner Circle have performed to a ...
(Date:7/21/2014)... (Philadelphia, PA) Patients who have a clot ... be treated with traditional blood-thinning medication or undergo ... comfortable that there is no difference in death ... more bleeding risks with the catheter procedure, according ... Medicine researchers. The study involved a review of ...
(Date:7/21/2014)... July 21, 2014 (HealthDay News) -- The "viral reservoir" ... detection and elimination, is established much earlier than previously ... new obstacles for those working to eradicate the AIDS-causing ... HIV Research Program. They said the presence of the ... a cure for a subtype of HIV, known as ...
(Date:7/21/2014)... (PRWEB) July 21, 2014 Western ... “Great College to Work For” by the Chronicle ... and also made the Honor Roll for the ... categories: Collaborative Governance, Compensation and Benefits, Confidence in ... Respect & Appreciation. , “Western University of Health ...
Breaking Medicine News(10 mins):Health News:2014 Cheap Wedding Dresses, Newest Items Offered by Professional Company Stwd.co.uk 2Health News:PowerObjects Joins the 2014 Microsoft Dynamics Inner Circle 2Health News:Temple study compares deep vein thrombosis therapies 2Health News:Temple study compares deep vein thrombosis therapies 3Health News:Temple study compares deep vein thrombosis therapies 4Health News:Animal Experiments Shed Light on HIV's Ability to Hide 2Health News:Western University of Health Sciences Elevated to “Great College to Work For” Honor Roll 2
... the experts are happy about the significant improvement in ... discovery of a new virus carried by bats ... ,Health and veterinary experts have singled out Indonesia, ... bird flu contagion is particularly worrisome. ,FAO's ...
... that a proud person could either be truly self-confident ... California study demonstrated that people have a propensity to ... authors term authentic pride, or they link it to ... ,While authentic pride was connected to more positive personality ...
... technique, called coherent anti-Stokes Raman cattering ... sclerosis. ,The researchers have studied ... the technique. ,Myelin is the fatty sheath coating ... efficient nerve fibre conduction. In diseases such as multiple sclerosis, ...
... there's one person who's still not convinced that Britney Spears is ... her soon to be ex-hubby Kevin Federline. ,A ... Britney is 'mentally unstable', and the reason behind her breakdown earlier ... ,"He thinks she's mentally unstable and too young to ...
... correction for clubfoot, a birth defect in which the foot ... compliance and fewer complications than the traditional brace used to ... professor of orthopedic surgery at the School of Medicine, designed ... active movement, preserve muscle strength in the foot and ankle ...
... cell startlingly similar to its human counterpart will likely ... organ tissue in people, two studies reported Wednesday. ... the inner-most layer of week-old rodent embryos, will provide ... diseases and injuries, the researchers said. ,"They ...
Cached Medicine News:Health News:Avian Flu Seen in Others Birds too 2Health News:Avian Flu Seen in Others Birds too 3Health News:Pride, Even the Hubristic Kind, Allows Us to Survive 2Health News:New Innovation in Clubfoot Treatment 2Health News:New Innovation in Clubfoot Treatment 3Health News:'Missing Link' Stem Cells may Shorten Path to Therapies 2Health News:'Missing Link' Stem Cells may Shorten Path to Therapies 3
Each handle is designed to fit a specific trephine size....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: